GlassScriptPhysician profile
Joseph E Snavely
NPI 1639516164
$19,647.58
in general payments reported to CMS, 2019-2025
25 companies · $1,927 in 2025
The $1,927 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,906 · 2020: $1,095 · 2021: $717 · 2022: $10K · 2023: $498 · 2024: $14.10 · 2025: $1,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380 · Travel and Lodging: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.80 |
| Travel and Lodging | $1,059.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Implanet America, INC. | $7,763.23 | 2021-2022 | |
| Stryker Corporation | $2,923.71 | 2019-2021 | |
| Nuvasive, INC. | $2,463.83 | 2019-2020 | |
| Pfizer INC. | $1,410.00 | 2022 | |
| Kalitec Direct LLC | $1,191.00 | 2022-2025 | |
| Alphatec Spine, INC | $1,059.18 | 2025 | Other - Miscellaneous |
| Arteriocyte Medical Systems, INC. | $764.14 | 2020-2022 | |
| Boston Scientific Corporation | $328.71 | 2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Zimmer Biomet Holdings, INC. | $287.36 | 2019-2021 | |
| Sanara Medtech INC. | $191.34 | 2024-2025 | Celleraterx, Celleraterx |
| Medtronic USA, INC. | $188.71 | 2019 | |
| Kyocera Medical Technologies, INC. | $177.77 | 2021 | |
| Medtronic, INC. | $158.46 | 2025 | Inceptiv |
| Organogenesis INC. | $145.57 | 2020-2022 | |
| Orthofix Medical, INC. | $129.61 | 2023 | Spinal-Stim, Spinal-Stim |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $120.58 | 2019 | |
| Xenix Medical LLC | $93.38 | 2019 | |
| Horizon Therapeutics Plc | $51.58 | 2021 | |
| Si-Bone, INC. | $44.78 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $41.90 | 2020-2025 | Exparel |
| Ethicon US, LLC | $29.55 | 2020 | |
| Integra Lifesciences Corporation | $27.43 | 2020 | |
| Davol INC. | $23.79 | 2023 | |
| Cerapedics INC. | $18.60 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Baxter Healthcare | $13.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Snavely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.